Peptic ulcer in surgery

Reading File
Finding Sources
Searching PubMed

"peptic ulcer disease" AND surgery

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
I now have comprehensive, high-quality content from multiple surgical textbooks. Let me compile the full answer.

Peptic Ulcer Disease - A Surgical Perspective

Sources: Bailey & Love's Short Practice of Surgery 28th Ed., Sabiston Textbook of Surgery, Schwartz's Principles of Surgery

1. Definition and Basic Pathology

Peptic ulcers are erosions in the GI mucosa that extend through the muscularis mucosae. Although the term "peptic" implies a role for pepsin, the key driver is acid - in the absence of acid, peptic ulcers simply do not occur. Nearly all ulcers heal when rendered achlorhydric with PPIs.
Common sites:
  • First part of the duodenum (most common)
  • Lesser curve of the stomach (near the incisura)
  • Stomal (after gastric surgery, near the jejunal-gastric mucosal junction)
  • Oesophagus and Meckel's diverticulum (ectopic gastric epithelium)
The ulcer characteristically develops at the junction of different epithelia, in the epithelium least resistant to acid damage.

2. Aetiology and Risk Factors

The two dominant causes are H. pylori and NSAIDs:
FactorAssociation
H. pylori90% of duodenal ulcers; 70-90% of gastric ulcers
NSAIDsBreak mucosal prostaglandin barrier
Cigarette smokingPredisposes and increases relapse rate
Zollinger-Ellison syndrome (gastrinoma)Massive acid hypersecretion
StressMajor surgery, burns (Curling's), brain injury (Cushing's)
Corticosteroids, alcoholSecondary risk factors
Pathogenesis: Ulcers arise when damaging factors (HCl, pepsin, NSAIDs, H. pylori, bile) overcome protective factors (mucosal bicarbonate, mucus, prostaglandins, adequate blood flow, cell renewal).

3. Gastric Ulcer Classification: Modified Johnson System

This classification is still surgically relevant because it guides operative choice:
TypeLocationAcid Level
I (50-60%)Lesser curve at incisuraLow to normal
II (15-20%)Gastric body + concurrent duodenal ulcerIncreased
III (20%)PrepyloricIncreased (behaves like DU)
IV (<10%)High on lesser curve, near GEJNormal
VAnywhereNormal (NSAID-induced)
Types II and III have excess acid and behave like duodenal ulcers. Type I occurs near the transitional zone between fundic and antral mucosa. Type IV is near the cardia and technically challenging to resect.

4. Clinical Features

Duodenal ulcer:
  • Epigastric pain relieved by food and antacids; classically wakes patient at night
  • More common in males (historically), though the gender gap is narrowing
  • Rarely malignant - giant DU can appear alarming but is confidently benign
Gastric ulcer:
  • Similar epigastric pain, but food may exacerbate it
  • Equal gender incidence; tends to affect older patients
  • MUST be biopsied - malignancy cannot be excluded clinically
  • Ulcerated gastric cancer can mimic a benign ulcer
Key distinction: Anterior duodenal ulcers tend to perforate; posterior duodenal ulcers tend to bleed (by eroding the gastroduodenal artery). "Kissing ulcers" = anterior + posterior DU simultaneously.

5. Investigations

  • Gastroduodenoscopy (OGD): Investigation of choice. Allows direct visualization, biopsy, H. pylori testing (CLO test/urease), and therapeutic intervention. Multiple biopsies (minimum 4-6) from all quadrants of a gastric ulcer are essential to maximize sensitivity for malignancy (single biopsy: 70% sensitivity; 4 biopsies: 95%; 7 biopsies: 98%).
  • Barium meal: Largely replaced by OGD. Double-contrast technique detects 80-90% of ulcers; single-contrast misses 50%.
  • CT scan: Required in suspected perforation - more accurate than plain CXR.
  • Serum gastrin: If ZES/gastrinoma is suspected.
  • Serum amylase: To differentiate peptic perforation from pancreatitis (amylase may be mildly elevated in both).

6. Medical Treatment

Antisecretory Agents

  • PPIs (omeprazole, pantoprazole, etc.): Most potent. Irreversibly block the H⁺/K⁺-ATPase pump. Render patients virtually achlorhydric. Heal virtually all benign ulcers within 2 weeks. Safe and well-tolerated.
  • H2-receptor antagonists (ranitidine, famotidine): Now largely superseded by PPIs.
  • Problem: Relapse is almost universal after stopping either agent unless H. pylori is eradicated.

H. pylori Eradication (Triple/Quadruple Therapy)

Eradication of H. pylori cures the disease in patients where it is the primary cause. Reinfection in adults is uncommon. Regimens typically use a PPI + two antibiotics (e.g., amoxicillin + clarithromycin) for 7-14 days. Quadruple therapy (PPI + bismuth + metronidazole + tetracycline) for resistant organisms.

7. Elective Surgery for PUD

Elective surgery for uncomplicated PUD is now very rarely performed due to the success of PPIs and H. pylori eradication. Surgery is considered for:
  • True refractory disease (failed 8-12 weeks PPI + confirmed H. pylori eradication)
  • Inability to eradicate H. pylori or stop NSAIDs
  • Non-compliance with medical therapy
  • Rare causes (ZES, Crohn's, sarcoidosis)
Goal of operative ulcer surgery: Reduce acid secretion (via vagotomy ± antrectomy) and/or resect the diseased mucosa.

Vagotomy-Based Procedures

ProcedureMechanismAcid ReductionNotes
Truncal vagotomyDivision of both vagal trunks above GEJ~50%Requires drainage (gastric stasis)
Selective vagotomyDivides gastric branches, preserves hepatic/coeliac~50%Still requires drainage
Highly selective vagotomy (HSV)Denervates only parietal cell mass; preserves antral innervation~50%No drainage needed; lowest morbidity; higher recurrence rate
  • Truncal vagotomy always requires a drainage procedure (e.g., Heineke-Mikulicz pyloroplasty or gastrojejunostomy) because antral denervation causes gastroparesis.
  • HSV (Figure 67.19 - Bailey & Love) preserves the crow's feet (nerve of Latarjet branches to antrum) and avoids the need for drainage.

Gastrectomy

OperationDescriptionIndication
Billroth IDistal gastrectomy + gastroduodenostomyStandard for gastric ulcer
Billroth II (Pólya)Distal gastrectomy + gastrojejunostomy, duodenum closedComplex DU with scarred duodenum
Truncal vagotomy + antrectomyRemoves gastrin-producing antrum + vagal driveLowest ulcer recurrence (1%) but highest morbidity
  • Vagotomy + antrectomy reduces peak acid output by ~85% (vs. ~50-70% for vagotomy alone).
  • Operations for gastric ulcer always include excision of the ulcer so malignancy can be excluded.

8. Complications of PUD and Their Surgical Management

A. Perforation

Epidemiology: Despite PPIs and eradication therapy, the incidence of perforated peptic ulcer has changed little. The profile has shifted to elderly females taking NSAIDs.
Clinical features:
  • Sudden-onset, severe generalised abdominal pain (peritoneal irritation by gastric acid)
  • Board-like rigidity, patient motionless, not moving with respiration
  • Initial tachycardia; pyrexia develops hours later as bacterial peritonitis supervenes
  • Elderly patients may have an atypically mild presentation (NSAIDs mask signs)
  • Fluid may track down right paracolic gutter → pain in epigastrium + RIF (mimics appendicitis)
Investigations:
  • Erect CXR: Free gas under diaphragm in >50% of cases
  • CT abdomen: Now preferred - more sensitive and accurate; also rules out pancreatitis
Erect CXR showing free gas under the right diaphragm in perforated duodenal ulcer
Erect CXR: free gas under the right diaphragm in perforated duodenal ulcer - Bailey & Love's
Treatment:
  1. Resuscitation + analgesia (do not withhold - adequate analgesia actually clarifies signs)
  2. Surgery: Upper midline laparotomy or laparoscopy
    • Thorough peritoneal toilet (remove all fluid and food debris)
    • Omental (Graham) patch repair: Suture closure of perforation ± reinforcement with a pedicle of omentum. For difficult closures, omental patch alone (without suture closure) is widely used.
    • Gastric ulcers: Excise if possible to exclude malignancy
    • Massive perforation (primary closure impossible): Distal gastrectomy + Roux-en-Y reconstruction
    • Postoperatively: NG suction, IV PPIs, then H. pylori eradication (mandatory)
  3. Conservative management: Possible only in selected patients with small, contained leaks and minimal contamination - any deterioration mandates immediate surgery
  4. Lifelong PPI therapy after perforation, especially if NSAIDs must be continued

B. Haemorrhage (Upper GI Bleeding)

PUD is the most common cause of upper GI bleeding (35-50% of cases). Bleeding occurs in 15-20% of patients with PUD. In-hospital mortality: 5-10%, rising to 33% when bleeding first occurs in hospitalized patients.
Forrest Classification of bleeding peptic ulcers (endoscopic):
ClassFindingRebleed Risk
IaActive arterial (spurting) bleedingVery high
IbActive oozing bleedingHigh
IIaVisible vessel (non-bleeding)~50%
IIbAdherent clot~25-30%
IIcFlat pigmented spotLow
IIIClean ulcer baseVery low
Management:
  1. Resuscitation: Large-bore IV access, blood products, IV PPI infusion
  2. Endoscopy within 24 hours (urgent in active/high-risk bleeding): Haemostatic clips, electrocoagulation, APC, heater probe. Epinephrine injection alone is insufficient.
  3. Repeat endoscopy for re-bleeding after initial success
  4. Interventional radiology (transarterial embolization): For failed endoscopic therapy, especially in high-risk surgical patients
  5. Surgery (if above fail):
    • Posterior DU (erodes gastroduodenal artery): Open duodenum longitudinally → under-run the bleeding vessel with deep sutures → close as pyloroplasty (transversely)
    • Gastric ulcer: Open stomach anteriorly → under-run the vessel → local excision of ulcer with biopsy to exclude malignancy
    • For massive/complex bleeding: Distal gastrectomy + Roux-en-Y
    • Definitive acid-lowering surgery is no longer routinely added - PPIs and H. pylori eradication achieve this medically (damage-control philosophy in elderly/unfit)

C. Gastric Outlet Obstruction (Pyloric Stenosis)

Chronic inflammation and healing → fibrosis → stenosis of the pyloric/duodenal outflow tract.
Presentation: Early satiety, anorexia, weight loss, nausea, vomiting, projectile vomiting of undigested food Metabolic consequence: Hypochloraemic, hypokalaemic metabolic alkalosis (loss of HCl + secondary hyperaldosteronism retaining Na⁺ in exchange for K⁺ and H⁺)
Management:
  1. NG decompression + correct fluid/electrolyte abnormalities first
  2. OGD to exclude malignancy (gastric cancer is now a more common cause)
  3. Endoscopic balloon dilation + H. pylori eradication (first-line)
  4. Surgery (if endoscopic treatment fails):
    • Vagotomy + antrectomy (preferred when possible)
    • Vagotomy + drainage procedure (Jaboulay gastroduodenostomy or gastrojejunostomy) when duodenal inflammation/scarring is too severe for resection

9. Elective Surgical Procedures - Summary Table

ProcedureAcid ReductionUlcer RecurrenceComplication Rate
Truncal vagotomy + drainage50-70%~10%Low-moderate
Truncal vagotomy + antrectomy~85%~1%Highest
Highly selective vagotomy~50%Variable (surgeon-dependent)Lowest

10. Post-Gastrectomy Complications

ComplicationMechanismTreatment
Dumping syndrome (early)Rapid gastric emptying → osmotic fluid shift to gutSmall frequent meals; lying after eating; octreotide
Late dumping (reactive hypoglycaemia)Rapid absorption → insulin overshootSmall, low-carbohydrate meals
Bile vomiting / Alkaline reflux gastritisBile reflux into stomachRoux-en-Y diversion (45-60 cm limb)
Small stomach syndromeLoss of receptive relaxationImproves with time
Afferent loop syndromeLong afferent limb obstruction (Billroth II)Convert to Billroth I or Roux-en-Y
Efferent loop obstructionAdhesions, stricture, retroanastomotic herniaOperative revision
Gastrocolic/gastrojejunocolic fistulaAnastomotic ulcer penetrates transverse colonCorrect nutrition + revisional surgery
Iron/B12/folate deficiencyLoss of IF, reduced acid for iron absorptionSupplementation
Postvagotomy diarrhoeaLoss of pyloric motor functionCholestyramine; antidiarrhoeals

11. Stress Ulceration

Occurs in ICU patients with major injury, sepsis, burns, or major surgery. Characterized by multiple superficial mucosal erosions (vs. single deep peptic ulcer). Both perforation and bleeding can occur.
Prevention (now standard of care): Prophylactic PPIs or H2-antagonists + sucralfate for all at-risk ICU patients. This has significantly reduced incidence.

Key Summary Points (Bailey & Love's Summary Box)

  • Most peptic ulcers are caused by H. pylori or NSAIDs
  • Duodenal ulcers are more common than gastric ulcers, but symptoms are indistinguishable
  • Gastric ulcers may be malignant - an ulcerated gastric cancer can mimic a benign ulcer
  • Gastric antisecretory agents + H. pylori eradication are the mainstays of treatment
  • Elective surgery is now very rarely performed
  • The common complications are perforation, bleeding, and stenosis
  • Treatment of perforated peptic ulcer is primarily surgical, though selected patients can be managed conservatively

Sources: Bailey and Love's Short Practice of Surgery 28th Edition | Sabiston Textbook of Surgery | Schwartz's Principles of Surgery 11th Edition | Mulholland & Greenfield's Surgery 7th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.